AI health tech Respiree closes $11.6m Series A

AI health tech Respiree closes $11.6m Series A

Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, has announced the successful closing of $11.6 million Series A financing round.

Singapore's Respiree closes $11.6M Series A financing round led by We Venture Capital and ClavystBio

Respiree, a Singapore-based health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, has announced the successful closing of a $11.6 million Series A financing round led by We Venture Capital and ClavystBio. The firm said in a statement on Wednesday that the round also had participation from Adaptive Capital Partners, conversion of note securities from Mayo Clinic’s Mayo…

Deals in brief: Respiree raises Series A funding, HeyMax expands with Krip acquisition, latest China deals, and more

Respiree raises Series A funding to scale health monitoring AI Respiree, a health tech company founded in Singapore, has raised USD 11.6 million in a Series A funding round co-led by We Venture Capital and ClavystBio. Other participants include Adaptive Capital Partners, Mayo Clinic’s Mayo Foundation for Medical Education and Research, Greenwillow Capital Management, Seeds Capital, and She1K. The company’s platform, 1Bio, integrates electronic h…